Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa

2003954 citationsJournal Article

Authors

Lisa Saiman · Columbia University

Bruce C. Marshall · Cystic Fibrosis Foundation

Nicole Mayer-Hamblett · University of Washington

Jane L. Burns · University of Washington

Alexandra L. Quittner · University of Florida

Debra A. Cibene

Sarah J. Coquillette

Ann Yunker Fieberg

Abstract

Azithromycin treatment was associated with improvement in clinically relevant end points and should be considered for patients with CF who are 6 years or older and chronically infected with P aeruginosa.

Topics & Keywords

Cystic Fibrosis Research Advances Pneumonia and Respiratory Infections Asthma and respiratory diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 290, Issue 13, pp. 1749-1749

DOI: 10.1001/jama.290.13.1749

Field-Weighted Citation Impact: 31.47